Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| CEO | Cox John | Sep 8, 2026 | Sell | $106.82K | 5,658 |
| Chief Commercial Officer | Friedl-Naderer Johanna | Sep 8, 2026 | Sell | $3.49K | 185 |
| Chief Medical Officer | Kerr Douglas | Sep 8, 2026 | Sell | $24.36K | 1,290 |
| Chief Commercial Officer | Friedl-Naderer Johanna | Sep 4, 2026 | Sell | $21.92K | 900 |
| Chief Medical Officer | Kerr Douglas | Sep 4, 2026 | Sell | $91.19K | 3,745 |
| Director | Rhodes Jason P | Aug 14, 2026 | Sell | $33.99M | 1,359,674 |
| Director | Rhodes Jason P | Aug 14, 2026 | Sell | $11.96M | 478,377 |
| Director | Rhodes Jason P | Aug 14, 2026 | Sell | $8.06M | 322,465 |
| Chief Commercial Officer | Friedl-Naderer Johanna | Aug 13, 2026 | Sell | $5.94K | 226 |
| CEO | Cox John | Aug 13, 2026 | Sell | $131.03K | 4,986 |
| CFO | Lucera Erick | Aug 13, 2026 | Sell | $47.23K | 1,797 |
| Chief Medical Officer | Kerr Douglas | Aug 13, 2026 | Sell | $40.89K | 1,556 |
| Director | Rhodes Jason P | Aug 13, 2026 | Sell | $7.03M | 268,354 |
| Director | Rhodes Jason P | Aug 13, 2026 | Sell | $2.47M | 94,415 |
| Director | Rhodes Jason P | Aug 13, 2026 | Sell | $1.67M | 63,643 |
| Director | Kersten Dirk | Jul 27, 2026 | Sell | $6.53M | 256,072 |
| Director | Kersten Dirk | Jul 27, 2026 | Sell | $140.32K | 5,388 |
| Director | Rhodes Jason P | Jul 7, 2026 | Sell | $2.88M | 124,379 |
| Director | Rhodes Jason P | Jul 7, 2026 | Sell | $698.84K | 29,587 |
| Director | Rhodes Jason P | Jul 7, 2026 | Sell | $1.45M | 62,543 |
| Director | Rhodes Jason P | Jul 7, 2026 | Sell | $350.62K | 14,844 |
| Director | Rhodes Jason P | Jul 7, 2026 | Sell | $1.14M | 49,193 |
| Director | Rhodes Jason P | Jul 7, 2026 | Sell | $275.53K | 11,665 |
| Director | Rhodes Jason P | Jul 7, 2026 | Sell | $118.05K | 5,000 |
| Director | Rhodes Jason P | Jul 6, 2026 | Sell | $5.77M | 253,039 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
